Connect with us

Business

Connecticut marijuana retailers report brisk adult-use sales in first week despite limited products

Published

on

Strong consumer demand, limited product availability and the debut of gummies highlighted the first week of recreational marijuana retail in Connecticut, with dispensaries likely eclipsing $2 million in sales during that period, according to industry sources and MJBizDaily projections based on state data.

To handle the increased business and avoid bottlenecks, retailers added staff and registers, shifted employees in from other adult-use markets, pushed online transactions and fulfilled orders outside for consumers waiting in line.

Recreational sales in Connecticut kicked off Jan. 10 at seven medical marijuana dispensaries licensed to transition to adult use.

Despite several significant retail restrictions, including quarter-ounce-purchase limits for flower, curbs on the use of some strain names and bans on certain product categories, Connecticut’s Department of Consumer Protection reported that adult-use sales surpassed $251,000 in the first seven hours of business.

Recreational sales in Connecticut this year are expected to reach $300 million-$375 million as more cultivators, manufacturers and retailers come online and will increase to $650 million-$800 million by 2026, according to the 2022 MJBiz Factbook.

As expected, the products that hit the shelves – flower, vapes and gummies – sold well.

Fine Fettle Dispensary, which has converted three of its four medical marijuana licenses into hybrid retail permits to serve recreational consumers, has seen transactions quadruple in the past week.

Meanwhile, its dispensaries in Newington, Stamford and Willimantic haven’t generated neighbor complaints, traffic jams or parking issues, assuaging some initial concerns of CEO Benjamin Zachs.

“It’s been a great, seamless process,” he said. “We’ve been really happy with how it’s going.”

Fine Fettle’s lowest-priced eighths, which cost just under $55, tax included, have been its top sellers.

The company opted to fulfill purchases primarily through online preorders and preselected pickup windows at its various outlets, with notification updates sent via email or text.

Fine Kettle’s customers, according to Zachs, have represented a cross section of Connecticut consumers and those from other states, age groups, gender, race and ethnicities.

“It goes to show how universal cannabis is as a product,” he added.

On the first day of recreational sales, lines wrapped around Zen Leaf’s dispensary in Meriden in south-central Connecticut, about a half-hour drive north of New Haven.

Customers cheered in line and were given free coffee and donuts.

“The excitement was palpable; people were super psyched,” said Darren Weiss, chief operating officer and general counsel of Verano Holdings, a Chicago-based multistate operator that owns two dispensaries in the state and CT Pharma, the market’s largest cannabis grower and product manufacturer.

Verano’s Meriden location tripled customer count on Day 1 – compared to a typical weekday of business under the state’s medical marijuana program – and has sustained the pace since then.

“We’ve continued to see that throughout the course of the week,” said Weiss, who traveled from Baltimore for the recreational market launch.

Sticking with gummies

Verano, which acquired CT Pharma in 2021, leveraged its production expertise gained in other recreational market launches in Massachusetts and New Jersey to outfit its 216,000-square-foot cultivation and manufacturing facility in the Hartford suburb of Round Hill.

The monthslong undertaking included equipment installs, training employees on operating procedures, bringing in its national kitchen and infusion staff as well as adding other personnel.

Under Connecticut’s adult-use program, gummy coloring is prohibited, a restriction that sent CT Pharma back to the drawing board.

After some research and development, the company was able to produce gummies with the same feel, taste and look – but no colors – as the gummies it sells in other state markets.

“Day One, we had gummies not only to supply our own store but the entire industry here in Connecticut,” said Weiss, who estimates the facility is producing about 80% of the state’s entire cannabis products.

“We have the capacity here, we’ve done this before,” he added.

“We know how important it is on Day One to have that full panoply, that full suite of products available to patients and customers.”

Consumer product shortfalls

With only one market supplier, The Botanist in Montville limited gummy package transactions per customer to ensure inventory lasted through the first week.

Fine Fettle was on the verge of selling out its line of gummy products but received a few shipments on Friday.

“We definitely want more product variety than anything,” Zachs said.

Demand has outpaced CT Pharma’s production modeling in the early going, Weiss admitted.

Kate Nelson, who oversaw The Botanist’s conversion to adult-use sales under the Acreage Holdings banner, expects the state’s four licensed producers – a catchall term in Connecticut for vertically integrated cultivators and manufacturers – to ramp up production in the coming weeks.

Expanding production licenses and approvals likely will also improve inventory levels and ease demand over time.

“We’re going to see a diversity of products that are available,” said Nelson, senior vice president of the Midwest and Northeast regions for New York-based MSO Acreage.

Until then, The Botanist will offer about 50 SKUs (stock-keeping units) for consumers compared to more than 200 on its medical marijuana menu, a result of supply constraints and regulatory restrictions.

Restrictions rein in retail potential

Connecticut’s adult-use market is one of the most restrictive in the nation.

It opened with only 13 licensed cannabis companies of any kind, which all paid steep premiums to convert their medical marijuana licenses to hybrid retail and production operations.

Dispensaries are charged a $1 million fee and producers a $3 million fee, though those rates could be halved if businesses agree to form separate joint ventures with two social equity applicants, an allowance that includes two additional licenses.

Potency caps and product bans have also hindered product availability and choice.

Under Connecticut’s adult-use program, THC is capped at 30% for flower and 60% for all other cannabis products – restrictions not faced by the MMJ market.

Products administered like medicine, including capsules, pills, suppositories and under-the-tongue sublinguals, are prohibited for recreational consumers.

Connecticut also implemented unusual classification systems that block medical and adult-use retailers from using traditional cannabis strain names such as Gelato, Gorilla Glue or Wedding Cake.

Instead, they’re marketed under pharmaceutical-sounding names such as Hybridol HI T25.13, Indicol VW T28.57 and Sativarin R T23.12.

In an effort to mitigate long checkout lines and educate consumers on its strains, The Botanist employed a team of staffers outside the store to take customer questions and log orders under tents on mobile tablets – a model perfected by the likes of In-N-Out and other fast-food service providers.

“It’s our responsibility as an operator in the program to be sharing that information and to be educating and make sure that when people walk out your door, they know what they’re getting, and they’re ultimately going to be happy with that purchase and that experience they had,” Nelson said.

Even with a record number of transactions on Day One – a 150% increase from a traditional weekday – The Botanist was able to move consumers through the buying process in less than 15 minutes, averting bottlenecks outside in the cold Connecticut winter.

“Our team was ready for this, and the model that we had worked,” added Nelson.

Despite the retail challenges, consumer demand is robust.

Fine Fettle’s Zachs expects a business bump in the months ahead, particularly in the wake of the holiday shopping season and as the seasonally sluggish first quarter gives way to spring.

“I’m happy for where we’ve been,” he said, “but really more excited about where we’re going.”

Source: https://mjbizdaily.com/connecticut-marijuana-retailers-report-brisk-adult-use-sales-in-first-week/

Business

Jio’s 1,600-Satellite LEO Constellation Gets Technical Green Light

Published

on

By

Reliance Jio has crossed a significant milestone in its space connectivity ambitions after its proposal to deploy a Low Earth Orbit (LEO) satellite constellation of around 1,600 satellites received a positive technical assessment from the Indian National Space Promotion and Authorisation Centre (IN-SPACe).

The evaluation, conducted jointly by IN-SPACe, the Indian Space Research Organisation (ISRO), and the Wireless Planning and Coordination (WPC) wing of the Department of Telecommunications, reportedly concluded that Jio’s proposed system meets the required technical standards and is comparable to leading global satellite broadband networks.

India’s Indigenous LEO Satellite Vision

Under the proposal, Reliance Jio plans to deploy between 1,600 and 1,650 satellites in Low Earth Orbit at an altitude of around 650 kilometres.

The planned constellation is expected to provide high-speed satellite connectivity across India, with approximately 32 satellites visible from any location at a given time. The company aims to roll out the network within the next two to three years, subject to regulatory approvals.

According to industry estimates, the satellite system could deliver 4.5 to 5 terabits per second (Tbps) of total data capacity, making it one of the largest satellite broadband projects proposed in India.

The project is expected to require an investment of $10–15 billion (approximately ₹95,000 crore to ₹1.42 lakh crore), reflecting the scale of infrastructure needed for satellite manufacturing, launches, ground stations, and user terminals.

Regulatory Process Moves Forward

Following the successful technical review, the proposal is expected to move into the next phase of regulatory approvals.

The government may now assist Jio in securing orbital slots, coordinating spectrum usage, and filing applications with the International Telecommunication Union (ITU), the global body responsible for managing satellite orbit and frequency allocations.

Obtaining orbital rights remains a critical step, as Low Earth Orbit has become increasingly competitive due to the growing number of satellite broadband projects being planned worldwide.

Officials also indicated that the proposed satellite architecture has been designed to coexist with future Indian LEO constellations, allowing multiple domestic operators to share orbital resources efficiently.

Broadband, Mobile Connectivity, and Strategic Applications

Jio plans to use the satellite network to provide a range of communication services, including satellite broadband, mobile backhaul, enterprise connectivity, and direct-to-device (D2D) satellite communication, particularly in remote and underserved regions where conventional telecom infrastructure is limited.

The company also intends to establish 20 to 22 ground stations across India to support network operations.

Apart from commercial telecommunications, officials have highlighted the project’s potential strategic importance. A domestically developed satellite constellation could strengthen India’s communication infrastructure, reduce dependence on foreign satellite operators, and support national security requirements.

Reports suggest preliminary discussions are underway regarding the possibility of integrating defence-related payloads into some satellites, enabling both civilian and strategic use.

Major Step for India’s Space and Telecom Sectors

Industry analysts view the technical clearance as an important milestone in India’s expanding private space ecosystem. If Jio secures the remaining regulatory approvals and international orbital clearances, the project could become the country’s first large-scale indigenous LEO satellite broadband network.

The initiative also aligns with India’s broader efforts to expand digital connectivity while strengthening its presence in the global satellite communications market.

Continue Reading

Business

Alleged Crores Pharma Scam Mastermind Arrested from Surat

Published

on

By

After evading law enforcement for nearly 13 years, an accused linked to a large-scale pharmaceutical fraud case has been arrested by Delhi Police from Surat, Gujarat. The suspect is alleged to have orchestrated a series of financial scams involving fake identities, forged documents, and dishonoured cheques used to procure high-value pharmaceutical raw materials.

Authorities say the accused, identified as Himmat Singh Lodha, is believed to have defrauded multiple pharmaceutical companies in Delhi of goods worth approximately ₹98 lakh before disappearing and remaining underground for years.

Fake Business Deals and Dishonoured Cheques Used in Fraud

Investigators claim the accused posed as a legitimate pharmaceutical trader and placed bulk orders for expensive drug ingredients, offering post-dated cheques as payment security.

In one documented case from 2013, he allegedly obtained around 550 kilograms of Gliclazide, a diabetes-related pharmaceutical ingredient, valued at over ₹26 lakh. When suppliers attempted to encash the cheques, they were reportedly returned with the remark “account closed.”

Following the transaction, the accused allegedly vacated his office and rented residence and disappeared without settling payments. He was later declared a proclaimed offender in 2016 after repeatedly failing to appear before court proceedings. Authorities had also issued a reward for information leading to his arrest.

Multiple Identities and Repeated Fraud Pattern

Police investigations further link the accused to another cheating case dating back to 2012, where he allegedly used a fake identity, “Kailash Jain,” to obtain a large consignment of Ambroxol HCL, a pharmaceutical compound used in cough medications. The value of that consignment was estimated at around ₹72 lakh.

Officials believe the accused followed a consistent modus operandi—posing as a credible businessman, securing high-value goods on deferred payment terms, and then disappearing after delivery while shutting down business operations.

Investigators suspect that forged business records, fake company credentials, and fabricated financial histories were used to build trust with suppliers and gain access to expensive raw materials.

Multi-State Surveillance Leads to Arrest in Surat

A special Crime Branch team tracked the accused through coordinated surveillance efforts across multiple cities, including Mumbai, Ahmedabad, and Surat. After nearly a month of technical monitoring and intelligence gathering, officials located and arrested him from a residential area in Surat.

Authorities also revealed that the accused had been involved in property-related activities while staying under the radar to avoid detection.

Growing Threat of Corporate Identity Fraud

The case highlights a rising trend of organised financial fraud targeting industries that rely heavily on trust-based transactions and deferred payments. Experts note that criminals increasingly exploit gaps in corporate verification systems by using fake GST registrations, temporary offices, and forged documentation to appear legitimate.

Cybercrime and financial fraud specialists warn that such schemes are becoming more complex with the widespread availability of digital business tools, making it easier to create convincing but fraudulent corporate identities.

Experts Urge Stronger Due Diligence in High-Value Transactions

Experts, including former IPS officer and cybercrime specialist Prof. Triveni Singh, emphasize the need for stricter verification procedures in commercial dealings. He noted that relying solely on paperwork or digital business profiles can expose companies to significant financial risk.

Authorities and industry experts recommend physical verification of business operations, bank account validation, and detailed background checks before engaging in high-value or deferred-payment transactions—particularly in sectors like pharmaceuticals, where single consignments can involve transactions worth crores.

Continue Reading

Business

EU Pressure Builds on Google as Regulators Face Calls for Massive Fine Over Search Practices

Published

on

By

A growing coalition of European industry groups is intensifying pressure on regulators to take decisive action against Google over allegations of unfair search practices that could reshape competition rules across the region’s digital economy.

Investigation Under Digital Markets Act Gains Momentum

The case is being examined by the European Commission under the European Union’s landmark Digital Markets Act (DMA), introduced to curb the dominance of major technology platforms and ensure fair competition.

Launched in March 2024, the investigation focuses on whether Google has been prioritising its own services in search results, potentially disadvantaging rival businesses that rely on online visibility to reach customers.

Industry Groups Demand Swift Action

Several prominent European organizations have jointly urged regulators to conclude the probe without further delay. They argue that prolonged investigations allow alleged anti-competitive practices to continue, putting European companies—especially startups—at a disadvantage.

Signatories include the European Publishers Council, the European Magazine Media Association, the European Tech Alliance, and EU Travel Tech.

In a joint statement, these groups warned that delays in enforcement are affecting innovation, profitability, and growth prospects for regional businesses competing in digital markets.

Google Denies Allegations

Google has rejected claims of bias, stating that its search algorithms are designed to deliver the most relevant and useful results to users. The company has also proposed adjustments to address regulatory concerns.

However, critics argue that these changes are insufficient and fail to address the core issue of market dominance.

Potential Billion-Euro Penalties

If found in violation of the DMA, Google could face significant financial penalties. Under EU rules, fines can reach a substantial percentage of a company’s global turnover, potentially amounting to billions of euros.

Regulators may also impose corrective measures requiring changes to business practices, which could have long-term implications for how digital platforms operate in Europe.

Wider Implications for Big Tech

The case highlights ongoing tensions between European regulators and major U.S. technology firms. In recent years, the EU has taken a more aggressive stance in enforcing competition laws, aiming to create a level playing field for local businesses.

A final ruling against Google could set a major precedent, influencing future enforcement actions and shaping the regulatory landscape for global tech companies operating within Europe.

As scrutiny intensifies, the outcome of the investigation is expected to play a critical role in defining the future of digital competition across the European Union.

Continue Reading

Trending

Copyright © 2022 420 Reports Marijuana News & Information Website | Reefer News | Cannabis News